Philip M. Sass
Berater bei Ben Franklin Technology Partners /Ventures/
Aktive Positionen von Philip M. Sass
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Ben Franklin Technology Partners /Ventures/
 Ben Franklin Technology Partners /Ventures/ Investment ManagersFinance Ben Franklin Technology Partners /Ventures/ (Ben Franklin Tech Partners) is a venture Capital firm founded in 1982. The firm is headquartered in Philadelphia, Pennsylvania. | Berater | - | - |
Karriereverlauf von Philip M. Sass
Ehemalige bekannte Positionen von Philip M. Sass
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| University of Illinois | Corporate Officer/Principal | - | - |
Morphotek, Inc.
 Morphotek, Inc. Miscellaneous Commercial ServicesCommercial Services Morphotek, Inc. operates as a biotechnology company. It develops and distributes biopharmaceutical products. The firm leverages its Morphodoma and Libradoma platform technologies to develop and research a pipeline of preclinical and clinical stage monoclonal antibodies for the treatment of cancer, inflammation and infectious diseases. The company was founded by Nicholas C. Nicolaides, Luigi Grasso and Philip M. Sass in May 2000 and is headquartered in Exton, PA. | Geschäftsführer | 01.05.2000 | - |
| Gründer | 23.02.2011 | - |
Ausbildung von Philip M. Sass
| Indiana University | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
Operativ
| Chief Operating Officer | 1 |
| Founder | 1 |
| Doctorate Degree | 1 |
Sektoral
| Consumer Services | 3 |
| Commercial Services | 2 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Morphotek, Inc.
Morphotek, Inc. Miscellaneous Commercial ServicesCommercial Services Morphotek, Inc. operates as a biotechnology company. It develops and distributes biopharmaceutical products. The firm leverages its Morphodoma and Libradoma platform technologies to develop and research a pipeline of preclinical and clinical stage monoclonal antibodies for the treatment of cancer, inflammation and infectious diseases. The company was founded by Nicholas C. Nicolaides, Luigi Grasso and Philip M. Sass in May 2000 and is headquartered in Exton, PA. | Commercial Services |
Ben Franklin Technology Partners /Ventures/
Ben Franklin Technology Partners /Ventures/ Investment ManagersFinance Ben Franklin Technology Partners /Ventures/ (Ben Franklin Tech Partners) is a venture Capital firm founded in 1982. The firm is headquartered in Philadelphia, Pennsylvania. | Finance |
- Börse
- Insiders
- Philip M. Sass
- Erfahrung
